When was SeraCare founded?

SeraCare was founded in 1984 and raised its 1st funding round 28 years after it was founded.

Where is SeraCare located?

SeraCare is headquartered in Milford, United States. It is registered at 37 BIRCH STREET,MILFORD,1757,MA.

How many employees does SeraCare have?

As of Aug 31, 2026, the latest employee count at SeraCare is 109.

Is SeraCare a funded company?

SeraCare is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Venture Debt round, raised on Apr 2012.

When was the latest funding round of SeraCare?

SeraCare's latest funding was a $***** Conventional Debt round on 2012, with participation from 1 investor.

What is the annual revenue of SeraCare?

Annual revenue of SeraCare is between $10M and $50M as on Sep 30, 2011

Where does SeraCare rank among its competitors?

SeraCare ranks 24th amongst 839 active competitors, of which 47 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of SeraCare?

SeraCare's top competitors include Abcam, Meridian Bioscience and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

SeraCare - 2026 Company Profile, Team, Funding & Competitors

Company Details

Quality control tools and reference materials for clinical laboratories and assay development. The organization provides a comprehensive suite of products and services tailored for IVD assay development, clinical lab quality control, and EQA & Proficiency. Their offerings include controls and reference materials, validation and qualification materials, cell culture reagents, plasma & serum diluents & derivatives, antibodies & conjugates, and custom services. They cater to various applications such as somatic cancer, inherited disease, reproductive health, and infectious disease. The company supports the diagnostic precision through webinars, events, and educational resources. They offer a range of products including Molecular solutions, Serology solutions, Antigen solutions, Variant Solutions, NGS Solutions, Panels, Specimens, Human Serum Albumin, Human Plasma & Serum, Human Blood Fractions, Bovine Serum Albumin, Virusys Antibodies and Controls, KPL Antibodies & Conjugates, KPL Immunoassay Reagents & Kits. They also offer custom services like Seraseq Custom Solutions for NGS Molecular & Serology Controls & Panels, EQA & Proficiency Panels, Antibodies & Reagents, Prospective Collections, Bulk Processed Plasma & Serum. The website offers features like cart, login, register, search, and subscription to diagnostic precision blogs.

Website: www.seracare.com/
Social
Part Of
Registered Address: 37 BIRCH STREET,MILFORD,1757,MA

Key Metrics

Founded Year

1984

Location

Milford, United States

Stage

Acquired

Latest Funding Round

Conventional Debt, 2012, $*****

Investors

MidCap Financial & 3 more

Ranked

24^th among 839 active competitors

Annual Revenue

$10M - $50M as on Sep 30, 2011

Employee Count

109 as on Aug 31, 2026

Investment & Acquisitions

KPL & 1 more

Similar Companies

Abcam & 977 more

Exit Details

Acquired by LGC (Nov 26, 2018)

View SeraCare's full profile

SeraCare is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Seracare Life Sciences Inc CIN: 1156295 , United States, Active		$10M - $50M (As on Sep 30, 2011)	-	-

SeraCare got acquired by LGC on Nov 26, 2018.

Click here to take a look at SeraCare's acquisition in detail

SeraCare has raised funding over 2 rounds. Its first funding round was on Apr 2012. Its latest funding round was a Conventional Debt round on 2012 for $*****. 1 investor participated in its latest round. SeraCare has 4 institutional investors.

Here is the list of recent funding rounds of SeraCare:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2012	8480	Conventional Debt	2181	2866	4991	9838
Apr 2012	2211863	Venture Debt	6961041	6968447	5516962	MidCap Financial

Access funding benchmarks and valuations. Sign up today!

View details of SeraCare's funding rounds and investors

The founders of SeraCare is Nelson Teng. Charlie Mamrak is the CEO of SeraCare.

Here are the details of SeraCare's key team members:

Nelson Teng: Founder of SeraCare and founder of 2 other companies, Vesta and Adeza Biomedical.
Contact Info: 1 email address
Charlie Mamrak: CEO of SeraCare.

View details of SeraCare's Founder profiles and Board Members

SeraCare's employee count trend

SeraCare has 109 employees as of Aug 26. Here is SeraCare's employee count trend over the years:

Uncover SeraCare's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SeraCare include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of SeraCare, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
4th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
5th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
6th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
7th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 1 others	56/100
8th	PL BioScience 2015, Aachen (Germany), Series A	Manufacturer of human platelet lysate products for cell culture applications	$13M	TechVision Fonds, Brightlands Venture Partners ... & 18 others	55/100
9th	Luminex 1995, Austin (United States), Acquired	Developer of instruments, reagents and kits for clinical diagnostics and life science research	-	Public Health Emergency, National Science Foundation ... & 1 others	55/100
10th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	PBM Capital, Breton Capital Ventures & 3 others	54/100
24th	SeraCare 1984, Milford (United States), Acquired	Quality control tools and reference materials for clinical laboratories and assay development	-	MidCap Financial, Kingfish Group & 2 others	44/100